ProAssurance (PRA) Insider Bruce Angiolillo Sells $891K of Stock

An insider at ProAssurance Corporation sold 35,652 shares on the same day as several other company leaders.

Reviewed by automated data checks against the source filing. How we make and check alerts

Bruce Angiolillo sold 35,652 shares of ProAssurance Corporation ($PRA) at an average price of $25, worth about $891,300, on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.

Find the original: PRA Form 4 filings on SEC EDGAR

PRA ProAssurance Corporation
$25 +4.08% year to date
Daily close · Jun 25, 2026

Key Points

  • Bruce Angiolillo sold 35,652 shares of ProAssurance on June 26, 2026, at an average price of $25.00 per share, totaling $891,300.
  • The sale occurred as ProAssurance stock traded near its 52-week high of $25.02 and just above its 50-day moving average of $24.61.
  • Six other insiders also disclosed sales on the same date, including the President of a subsidiary and the President of Healthcare Professional Liability.

Get $PRA trade alerts by text

We text you when insiders, Congress or big funds trade $PRA. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated ProAssurance Corporation alert may contain errors. Disclosures

Bruce Angiolillo sold 35,652 shares of ProAssurance Corporation (NYSE: PRA) on June 26, 2026. The transaction was valued at $891,300, based on an average selling price of $25.00 per share. This move was disclosed in a filing with the Securities and Exchange Commission.

ProAssurance Insider Selling Activity

The sale by Bruce Angiolillo was part of a much larger wave of selling by company leaders on June 26, 2026. Kevin Merrick Shook, the President of a subsidiary, sold 53,237 shares for about $1.33 million. Samuel JR. Di Piazza also trimmed his position, selling 44,952 shares for a total of $1.12 million.

Other executives joined in as well. Robert David Francis, the President of Healthcare Professional Liability, sold 31,196 shares for $779,900. Fabiloa Cobarrubias sold 25,184 shares for $629,600, while Staci Pierce and Richard Bielen each sold 10,621 shares, valued at $265,525 each. All of these transactions took place at the $25.00 price point and none were reported as being part of a pre-arranged 10b5-1 trading plan, which is a tool insiders use to schedule trades in advance to avoid conflict of interest concerns.

ProAssurance Stock Performance

On Friday, ProAssurance shares were trading at $25.00. This is very close to the top of the company's 52-week range, which has seen a low of $22.80 and a high of $25.02. The stock is currently trading slightly above its 50-day moving average of $24.61 and its 200-day moving average of $24.30. Investors often watch these moving averages—the average price over a set period—to see if a stock is trending up or down. With a price-to-earnings (P/E) ratio of 19.84, the company is priced at roughly 20 times its annual earnings per share.

Recent Earnings for ProAssurance

ProAssurance reported $1.10 billion in revenue for its most recent fiscal period, though revenue growth was down 4.9%. The company maintains a net margin of 5.95% and a return on equity of 5.07%. These figures help show how much profit the company keeps from its sales and how efficiently it uses shareholder money. The company is scheduled to release its next set of financial results on August 4, 2026.

Insurance and Risk Solutions

ProAssurance Corporation is an insurance provider that focuses on specialty property and casualty coverage. It is well-known for offering professional liability insurance to doctors, hospitals, and lawyers. It also handles workers' compensation and medical technology liability. Because its business is tied to professional risks, its financial health depends on accurately pricing those risks and managing its investment portfolio. This insider selling comes at a time when the stock has reached a yearly peak, though the company continues to maintain a steady footprint in the healthcare liability market.

Future Outlook

While the cluster of sales on June 26 is notable for its size and timing, it does not necessarily signal a change in the company's fundamental business. Investors often look toward the next earnings report in August to see if the company's revenue trends improve. As with all 13F and insider filings, these reports show past actions and may not reflect what these insiders hold today.

Source: Bruce Angiolillo's Form 4 filing on $PRA (Jun 26, 2026). Find the original filing: PRA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $PRA trade alerts by text